Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia

This subgroup analysis evaluated the effect of once-daily oral deferasirox on labile plasma iron (LPI) levels in patients from the prospective, 1-yr, multicentre ESCALATOR study. Mean baseline liver iron concentration and median serum ferritin levels were 28.6 ± 10.3 mg Fe/g dry weight and 6334 ng/m...

Descripción completa

Detalles Bibliográficos
Autores principales: Daar, Shahina, Pathare, Anil, Nick, Hanspeter, Kriemler-Krahn, Ulrike, Hmissi, Abdel, Habr, Dany, Taher, Ali
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2009
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730549/
https://www.ncbi.nlm.nih.gov/pubmed/19191863
http://dx.doi.org/10.1111/j.1600-0609.2008.01204.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730549/
https://www.ncbi.nlm.nih.gov/pubmed/19191863
http://dx.doi.org/10.1111/j.1600-0609.2008.01204.x

Ejemplares similares